4.3 Review

Endocannabinoids and Immunity

Journal

CANNABIS AND CANNABINOID RESEARCH
Volume 1, Issue 1, Pages 59-66

Publisher

MARY ANN LIEBERT, INC
DOI: 10.1089/can.2016.0002

Keywords

endocannabinoid; immunology; immunosuppression

Funding

  1. Fondazione Italiana Sclerosi Multipla (FISM) [2013/R/8]

Ask authors/readers for more resources

Over the last 10 years, a great boost of knowledge accumulated on the immunomodulatory and anti-inflammatory properties of endocannabinoids (eCBs). In this scenario, these bioactive lipids, which are produced by most immune cells along with a set of receptors and enzymes that regulate their synthesis and degradation, act as secondary modulators and increase or decrease a plethora of immune functions. In this review, the manifold immunomodulatory effects of the main eCBs in different compartments of innate and adaptive immunity will be discussed, suggesting that they could be considered as master regulators of innate-adaptive immune axis and as potent immunoresolvents.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available